Compare Lustrum:Chiome Bioscience Inc.:4583

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Chiome Bioscience Inc. 4583 Medicals 東証グロース December 1, 2000 2011.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Chiome Bioscience Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Chiome Bioscience Inc. Balance Sheet 2023年12月期 Chiome Bioscience Inc. Balance Sheet 2022年12月期 Chiome Bioscience Inc. Balance Sheet 2021年12月期 Chiome Bioscience Inc. Balance Sheet 2020年12月期 Chiome Bioscience Inc. Balance Sheet 2019年12月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Cash and Cash Equivalents
(Percent)
1,326down
1,727down
(78.0%)up
1,791down
(76.6%)down
2,686up
(76.9%)up
2,106
(75.0%)
Other Current AssetsHelp
(Percent)
304down
365down
(16.5%)down
426down
(18.2%)up
562up
(16.1%)down
455
(16.2%)
Tangible Fixed AssetsHelp
(Percent)
1down
2down
(0.1%)down
4down
(0.2%)down
7down
(0.2%)down
11
(0.4%)
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
0
-
0
-
0
-
Investments and OthersHelp
(Percent)
-1,631down
121up
(5.5%)up
118down
(5.1%)down
239up
(6.8%)down
236
(8.4%)
Total AssetsHelp
(Percent)
-
(100%)
2,215
(100%)
2,339
(100%)
3,495
(100%)
2,808
(100%)
Total Current LiabilitiesHelp
(Percent)
0
-
425down
(19.2%)up
446up
(19.1%)up
385up
(11.0%)up
187
(6.6%)
Total Long-term LiabilitiesHelp
(Percent)

-
0
-
0
-
0
-
0
-
Shareholder's EquityHelp
(Percent)

-
1,791down
(80.8%)down
1,893down
(80.9%)down
3,110up
(89.0%)down
2,622
(93.4%)
Total LiabilitiesHelp
(Percent)
-
(100%)
2,215
(100%)
2,339
(100%)
3,495
(100%)
2,808
(100%)

Chiome Bioscience Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Chiome Bioscience Inc. Profit and Loss Account 2023年12月期 Chiome Bioscience Inc. Profit and Loss Account 2022年12月期 Chiome Bioscience Inc. Profit and Loss Account 2021年12月期 Chiome Bioscience Inc. Profit and Loss Account 2020年12月期 Chiome Bioscience Inc. Profit and Loss Account 2019年12月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Amount of Sales
(Percent)
682
(100%)
631
(100%)
713
(100%)
481
(100%)
448
(100%)
Total Sales
(Percent)
682
(100%)
631
(100%)
713
(100%)
481
(100%)
448
(100%)
Cost of SalesHelp
(Percent)
284up
(41.6%)down
282down
(44.7%)up
290up
(40.7%)down
236up
(49.0%)up
163
(36.4%)
Other Costs and RevenueHelp 1,619up
(237.2%)down
1,592down
(252.3%)down
1,902up
(266.8%)down
1,539down
(320.1%)down
1,688
(377.2%)
Total CostsHelp 1,902 1,874 2,193 1,775 1,851
Net RevenueHelp 399up
(58.4%)up
349down
(55.3%)down
422up
(59.3%)up
245down
(51.0%)down
285
(63.6%)
Earnings Before TaxHelp -1,215up
(-178.0%)up
-1,238up
(-196.2%)up
-1,466down
(-205.7%)up
-1,291up
(-268.4%)up
-1,401
(-313.1%)
Net IncomeHelp -1,220up
(-178.8%)up
-1,243up
(-197.0%)up
-1,480down
(-207.6%)up
-1,294up
(-269.1%)up
-1,404
(-313.6%)
当期純利益 -1,220 -1,243 -1,480 -1,294 -1,404

Chiome Bioscience Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Chiome Bioscience Inc. Cash Flow Statement 2023年12月期 Chiome Bioscience Inc. Cash Flow Statement 2022年12月期 Chiome Bioscience Inc. Cash Flow Statement 2021年12月期 Chiome Bioscience Inc. Cash Flow Statement 2020年12月期 Chiome Bioscience Inc. Cash Flow Statement 2019年12月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
-1,069up
(-100.0%)down
-1,191down
(-100.0%)down
-1,131up
(-97.0%)down
-1,360up
(-70.0%)up
-1,537
(-98.3%)
Investing Cash Flow(ICF)Help
(Percent)

-
0up
(0.0%)up
-35down
(-3.0%)down
-4
(-0.2%)up
-4
(-0.2%)
Financing Cash FlowHelp
(Percent)
667down
(62.4%)down
1,127up
(94.6%)up
271down
(23.3%)down
1,944up
(100.0%)up
1,341
(85.8%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)

-
-0down
(0.0%)down
-0up
(0.0%)up
-0up
(0.0%)up
-23
(-1.5%)
Net Increase and Decrease in Cash and Cash Equivalentsn -402down
(-37.6%)down
-64up
(-5.3%)up
-895down
(-76.7%)down
580up
(29.9%)up
-223
(-14.2%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Chiome Bioscience Inc.

Company where related level is highHelp

MIZUHO MEDY CO.,LTD.
MUROMACHI CHEMICALS INC.
SSP CO.,LTD.
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
TORII PHARMACEUTICAL CO.,LTD.
Noile-Immune Biotech Inc.
K Pharma,Inc.
Mitsubishi Tanabe Pharma Corporation
WAKAMOTO PHARMACEUTICAL CO.,LTD.
ZERIA PHARMACEUTICAL CO.,LTD.